Compagnie Lombard Odier SCmA reduced its holdings in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 77.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,221 shares of the pharmacy operator’s stock after selling 74,414 shares during the period. Compagnie Lombard Odier SCmA’s holdings in Walgreens Boots Alliance were worth $1,542,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also made changes to their positions in WBA. Westside Investment Management Inc. increased its holdings in shares of Walgreens Boots Alliance by 10.4% in the second quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock valued at $102,000 after purchasing an additional 125 shares during the period. Zions Bancorporation increased its holdings in shares of Walgreens Boots Alliance by 983.3% in the third quarter. Zions Bancorporation now owns 1,365 shares of the pharmacy operator’s stock valued at $105,000 after purchasing an additional 1,239 shares during the period. Bristlecone Advisors LLC acquired a new position in shares of Walgreens Boots Alliance in the third quarter valued at about $135,000. Financial Advocates Investment Management acquired a new position in shares of Walgreens Boots Alliance in the fourth quarter valued at about $125,000. Finally, Fieldpoint Private Securities LLC increased its holdings in shares of Walgreens Boots Alliance by 428.6% in the fourth quarter. Fieldpoint Private Securities LLC now owns 1,850 shares of the pharmacy operator’s stock valued at $134,000 after purchasing an additional 1,500 shares during the period. 60.93% of the stock is currently owned by institutional investors.
A number of analysts have recently commented on the company. Zacks Investment Research downgraded Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research note on Monday, January 22nd. Mizuho set a $87.00 target price on Walgreens Boots Alliance and gave the stock a “buy” rating in a research note on Wednesday, January 24th. ValuEngine downgraded Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research note on Friday, February 2nd. Evercore ISI assumed coverage on Walgreens Boots Alliance in a research note on Thursday, January 4th. They issued an “outperform” rating and a $80.00 target price on the stock. Finally, Loop Capital set a $90.00 target price on Walgreens Boots Alliance and gave the stock a “buy” rating in a research note on Wednesday, January 3rd. One investment analyst has rated the stock with a sell rating, eleven have issued a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus price target of $84.75.
Walgreens Boots Alliance stock opened at $66.27 on Thursday. The stock has a market capitalization of $65,998.37, a P/E ratio of 18.31, a price-to-earnings-growth ratio of 1.10 and a beta of 1.21. The company has a current ratio of 0.96, a quick ratio of 0.47 and a debt-to-equity ratio of 0.48. Walgreens Boots Alliance Inc has a 1 year low of $63.82 and a 1 year high of $87.79.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.27 by $0.01. The company had revenue of $30.74 billion for the quarter, compared to the consensus estimate of $30.39 billion. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. Walgreens Boots Alliance’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.10 earnings per share. equities analysts forecast that Walgreens Boots Alliance Inc will post 5.79 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Monday, March 12th. Shareholders of record on Thursday, February 15th were given a dividend of $0.40 per share. The ex-dividend date was Wednesday, February 14th. This represents a $1.60 dividend on an annualized basis and a yield of 2.41%. Walgreens Boots Alliance’s dividend payout ratio is currently 44.20%.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.